119 episodes

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

The Long Run with Luke Timmerman Timmerman Report

    • Science
    • 4.8 • 5 Ratings

"The Long Run"

Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.

Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.

    Ep121: Samantha Truex on Going Upstream Against Severe Asthma

    Ep121: Samantha Truex on Going Upstream Against Severe Asthma

    Samantha Truex, CEO of Upstream Bio, on a new approach to treating severe asthma and other inflammatory diseases.

    • 1 hr 3 min
    Ep120: Tim Lu on Gene Circuits for Cell Therapy

    Ep120: Tim Lu on Gene Circuits for Cell Therapy

    Tim Lu, CEO of Senti Biosciences, on developing gene circuits for cell therapy.

    • 1 hr 4 min
    Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease

    Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease

    Jo Viney, CEO of Seismic Therapeutic, on discovering new treatments for autoimmune disease.

    • 1 hr 2 min
    Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes

    Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes

    Ivan Liachko, CEO of Seattle-based Phase Genomics, on assembling accurate genomes and interactomes. He also discusses immigrating from Ukraine as a child, and what brought him and his family to the US.

    • 1 hr 8 min
    Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World

    Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World

    Dr. Sanduk Ruit of the Tilganga Institute in Kathmandu on restoring eyesight with affordable cataract surgery for the developing world.

    • 1 hr 1 min
    Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience

    Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience

    Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, on precision neuroscience drug development.

    • 58 min

Customer Reviews

4.8 out of 5
5 Ratings

5 Ratings

You Might Also Like

STAT
BioCentury
Biotech 2050
Nature Biotechnology
The Bio Report
Matt Pillar

More by HeadStepper Media

J.D. Biersdorfer and Pedro Rafael Rosado
Pedro Rafael Rosado & Christopher Mele
Peppergreen Media
Connecticut Health Investigative Team